Alexander J. Aber

Representative Experience

Representative M&A Transactions

• Represented Shift4 Payments (NYSE: FOUR) in connection with its acquisition of VenueNext
• Represented Bottomline Technologies (NASDAQ: EPAY) in connection with its acquisition of TreasuryXpress
• Represented Shift4 Payments (NYSE: FOUR) in connection with its acquisition of 3dcart 
• Represented Altman Vilandrie & Company in its merger with Solon Management Consulting to form Altman Solon 
• Represented UnitedLex in its acquisition of Paul Hastings’ data science team and suite of AI software assets
• Represented The Boston Consulting Group in the sale of its SOURCE AI technology to DataRobot
• Represented Recorded Future, a threat intelligence company, in its sale of a controlling interest in the company valued at $780 million to Insight Partners
• Represented Indigo Ag, Inc. in its acquisition of TellusLabs 
• Represented Inovalon Holdings Inc. (Nasdaq: INOV) in its $1.2B acquisition of ABILITY Network. 
• Represented Dell Technologies in its $145.8 million sale of Mozy, Inc. to Carbonite, Inc. (Nasdaq: CARB)
• Represented Good Start Genetics, Inc. in its acquisition by Invitae Corporation (NYSE: NVTA) 
• Represented The Boston Consulting Group in its acquisition of assets from digital design firm MAYA Design
• Represented Komand, Inc. in its acquisition by Rapid7, Inc. (Nasdaq: RPD)
• Represented Lux Research, Inc. in its acquisition by private equity sponsor Bregal Sagemount
• Represented Dell EMC in the sale of EMC’s enterprise content division to Open Text Corporation (Nasdaq: OTEX) (TSX: OTC) for $1.62B 
• Represented Staples, Inc. (NYSE: SPLS) in the sale of its Staples Print Solutions business to Taylor Communications, Inc.
• Represented Shopify Inc. (NYSE: SHOP)(TSE: SH) in its acquisition of Kit CRM Inc.
• Represented EMC Corporation in its acquisition of Graphite Systems, Inc.
• Represented SOFAR S.p.A. in the acquisition of its surgical robotics division by TransEnterix (NYSE MKT: TRXC) in a cash and stock deal valued at up to approximately $100 million
• Represented Quantia, Inc. in its sale to Physicians Interactive, Inc. (a wholly-owned subsidiary of Merck)
• Represented EMC Corporation in the sale of Syncplicity LLC to Skyview Capital
• Represented Fortress Investment Group LLC in its acquisition of MicroFinancial Incorporated (Nasdaq: MFI)
• Represented EMC Corporation in its acquisition of The Cloudscaling Group, Inc.
• Represented Hittite Microwave Corporation (Nasdaq: HITT) in its approximately $2 billion sale to Analog Devices Inc. (Nasdaq: ADI)
• Represented Autism Intervention Specialists, LLC in its sale to Pacific Child & Family Associates, LLC, a Great Point Partners I, L.P. portfolio company
• Represented Isilon Systems LLC, a subsidiary of EMC, in its acquisition of Likewise Software, Inc.
• Represented Alere Inc. (NYSE: ALR) in its $270 million acquisition of eScreen, Inc.
• Represented Alere in its acquisition of Pregnancy.org, LLC
• Represented Alere in its acquisition of RMD Networks, Inc.
• Represented 38 Studios, LLC in its acquisition of Big Huge Games from THQ Inc. (Nasdaq: THQI)
• Represented Alere in the sale of its vitamins and nutritional supplements business to Aland (HK) Holding Limited
• Represented Microline Surgical, Inc. (a subsidiary Hoya Corporation), in its acquisition of Starion Instruments Corp.
• Represented Vidus Ocular in its sale to Opko Health, Inc. (NYSE: OPK)
• Represented EMC in its acquisition of Document Sciences Corporation (Nasdaq: DOCX)
• Represented Spotfire Holdings, Inc. in its sale to TIBCO Software, Inc. (Nasdaq: TIBX)
• Represented Avaki Corporation in its sale to Sybase, Inc.
• Represented Infogate, Inc. in its sale to America Online, Inc.

Representative Financing Transactions

• Represented Global Frontier Investments as lead investor in ColdQuanta’s $32 million Series A Financing
• Represented Dell Technologies as strategic investor in Exotec Solutions’ $90 million Series C Financing
• Represented Akamai Technologies as strategic investor in InfoSum’s $15 million Series A Financing
• Represented Ovia Health (formerly known as Ovuline) in its $10 million Series A Financing 
• Represented Ovuline, Inc. in connection with its preferred stock financing led by Martin Ventures
• Represented Safeguard Scientifics, Inc. (NYSE: SFE) in connection with $9 million Series B financing of meQuilibrium
• Represented Continuum Analytics, Inc. in connection with $24 million Series A financing led by General Catalyst and BuildGroup
• Represented Safeguard Scientifics in connection with $14.5 million Series B financing of Propeller Health, Inc.
• Represented Safeguard Scientifics in connection with $10 million Series B financing of Syapse, Inc.
• Represented Safeguard Scientifics in connection with $17 million Series B financing of InfoBionic, Inc.
• Represented Zumper, Inc. in connection with $6.5 million Series A financing led by Kleiner Perkins Caufield & Byers
• Represented Safeguard Scientifics in connection with $10 million Series B financing and recapitalization of Quantia, Inc.
• Represented Good Start Genetics, Inc. in $28 million mezzanine financing with Capital Royalty, L.P.
• Represented Skyline Ventures and Safeguard Scientifics in connection with $28 million Series D financing of Crescendo Bioscience, Inc.
• Represented Adage Capital Partners, L.P. and funds managed by T. Rowe Price Associates, Inc. as lead investors in $75 million Series B financing of Ultragenyx Pharmaceutical Inc.
• Represented Adage Capital Partners in $55 million Series B financing of Puma Biotechnology Inc. and related reverse-merger into a public company
• Represented Safeguard Scientifics in connection with $35 million Series D financing of NovaSom, Inc.
• Represented Safeguard Scientifics in connection with $45 million Series D financing of PixelOptics Inc.
• Represented Good Start Genetics in connection with $18 million Series A financing led by funds affiliated with OrbiMed Advisors, Safeguard Scientifics and SV Life Sciences
• Represented 38 Studios, LLC in connection with Class B Unit financing led by Curt Schilling

Representative Strategic Transactions 

• Represented Good Start Genetics, Inc. in connection with collaboration and distribution arrangements with Perkin Elmer Inc. (NYSE: PKI)
• Represented 38 Studios, LLC in connection with distribution and publishing arrangements for Kingdoms of Amalur: Reckoning with Electronic Arts Inc. (Nasdaq: EA)
• Represented Done. Corporation in connection with a domain name lease and purchase arrangement for www.done.com with DONE! Ventures, LLC